And, no, I’m NOT referring to the type Bob Wilson discusses in a recent investigative report...
First up, and timely indeed, is a post from friend and colleague Sandy Blunt about the integration of guidelines with medical bill review. Medata ran a large sample of medical bills from a very well managed work comp payer against medical guidelines and identified “15 percent in cost savings from questioned medical procedures” – over and above what the payer was already finding. Now, I’d note that “questioned” does not mean “actual”, nor should it. However, it does indicate a major opportunity that I daresay many payers are missing out on; employing guidelines as part of the bill review process.
Compounding drugs isn’t just for people anymore! A colleague sent me a link to a story of a drug dealer in Texas that has been selling performance-enhancing drugs for racing horses. Good to know they aren’t limiting their expertise to just us humans!
Millennium Labs and Texas Mutual just inked a deal wherein Millennim will be providing drug testing services for claimants prescribed opioids. (ML is an HSA consulting client). Texas Mutual has been at the forefront of opioid management for a couple years now; this further enhances their program.
The Claims and Litigation Management Alliance is hosting what looks to be an interesting conference in January; the NYTimes’ Barry Meier will be keynoting; Barry has written several books on opioids and published articles on physician dispensing and opioid usage in work comp